# FDA Inspection 1179016 - Vitalant - August 30, 2022

Source: https://www.keypedia.com/records/fda_inspections/vitalant/49feb95f-ce21-4e21-b201-930650d612ed
Source feed: FDA_Inspections

> FDA Inspection 1179016 for Vitalant on August 30, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1179016
- Company Name: Vitalant
- Inspection Date: 2022-08-30
- Classification: No Action Indicated (NAI)
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1179016 - 2022-08-30](https://www.keypedia.com/records/fda_inspections/vitalant/5d110524-6946-4f25-bf35-283dcf7426e1)
- [FDA Inspection 1028044 - 2017-09-22](https://www.keypedia.com/records/fda_inspections/vitalant/af669d1c-2909-426c-802d-1ed74d7d9239)
- [FDA Inspection 929879 - 2015-06-10](https://www.keypedia.com/records/fda_inspections/vitalant/8fd31dc1-2a71-4674-9150-0417b0f323be)
- [FDA Inspection 819643 - 2013-02-21](https://www.keypedia.com/records/fda_inspections/vitalant/5d923b54-f89d-4c16-8425-e430ee803ad2)
- [FDA Inspection 729457 - 2011-06-09](https://www.keypedia.com/records/fda_inspections/vitalant/0b140a90-29bd-42c7-b525-e01062171024)

Company: https://www.keypedia.com/companies/vitalant/df0b999d-3414-448f-9e01-2419ebf4c8f6

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d